Увійти

Готові списки джерел за темами / Hepatitis B and Hepatitis C / Статті в журналах

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Hepatitis B and Hepatitis C.

Статті в журналах з теми "Hepatitis B and Hepatitis C"

Автор: Grafiati

Опубліковано: 3 червня 2025

Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Hepatitis B and Hepatitis C".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Jain, Ravi, and Ashok Yadav. "Hepatitis B Versus Hepatitis C in Blood Donors." Annals of Applied Bio-Sciences 4, no. 1 (2017): A8—A13. http://dx.doi.org/10.21276/aabs.2017.1306.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar, and Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV." Professional Medical Journal 21, no. 04 (2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Повний текст джерела

Анотація:

Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Billah, Mustansar, Syed Muhammad Raza Shah, and Muhammad Mujtaba Hashir. "HEPATITIS B AND HEPATITIS C." Professional Medical Journal 25, no. 08 (2018): 1245–51. http://dx.doi.org/10.29309/tpmj/18.4766.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Viana, Daniel Rodrigues, Nathalia Mundoco Veloso, Osvaldo Carvalho Neto, Nicolas Garcia Papacosta, Gabriel Martins Nunes, and Virgílio Ribeiro Guedes. "Hepatite B e C: diagnóstico e tratamento." Revista de Patologia do Tocantins 4, no. 3 (2017): 73. http://dx.doi.org/10.20873/uft.2446-6492.2017v4n3p73.

Повний текст джерела

Анотація:

INTRODUÇÃO: As hepatites virais são consideradas as principais doenças hepáticas, podendo levar a quadros mais graves, como a cirrose e o carcinoma hepatocelular, tornando-se um importante problema de saúde pública. Tem distribuição global com áreas de altos índices de endemicidade, sobretudo em países asiáticos. Os principais agentes envolvidos são os vírus da hepatite A, B, C, D, E. O vírus da hepatite B e C se destacam nesse meio devido à grande capacidade de cronificação. As formas de transmissão são basicamente através do contato com fluidos corporais infectados, através de transfusões sa

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Huma Qureshi, Saeed Akhter, Hassan Mahmood, et al. "Overview of Hepatitis C Elimination Efforts in Pakistan and the Launch of Prime Minister’s Programme for the Elimination of Hepatitis C." Journal of the Pakistan Medical Association 74, no. 12 (2024): 2188–90. http://dx.doi.org/10.47391/jpma.24-97.

Повний текст джерела

Анотація:

Hepatitis B and C are serious viral infections that cancause liver damage and death. According to the WorldHealth Organization (WHO), there are currently 2.8 millionpeople living with hepatitis B in Pakistan, and 9.8 millionpeople living with hepatitis C.1 These numbers representa significant burden of disease for the country. Thecurrent prevalence of hepatitis B in Pakistan is 1.1%,which corresponds to one-quarter of the burden of thedisease in the Eastern Mediterranean region.1 Theprevalence of hepatitis C is 7.5%, which is the highest inthe world. Almost 37,000 people die each year in Pakis

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Shahbaz, Tazeem, Ghulam Farid, Raja Sajjad Asghar, and Abdul Rashid. "HEPATITIS B AND C." Professional Medical Journal 22, no. 11 (2015): 1383–89. http://dx.doi.org/10.29309/tpmj/2015.22.11.859.

Повний текст джерела

Анотація:

Background and Aims: The working conditions of Health care workers (HCW’S)expose them for a constant threat of contracting and spreading hepatitis B (HBV) and C virus(HCV) not only to their patients but family members as well. The aim of this study was to assessthe knowledge and attitude toward hepatitis B and C infection among the health-care workersand correlate the level of awareness to their behavior towards prevention of the disease. StudySettings: The study was conducted in Rashid Latif medical college and its two affiliated hospitals(Arif memorial teaching hospital and Hameed Latif Hosp

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Tagar, Muhammad Paryal, Mujeeb Rehman Abbasi, Mohammad Rafique Pathan, and Hafeezullah Shaikh. "HEPATITIS B & C;." Professional Medical Journal 24, no. 02 (2017): 278–81. http://dx.doi.org/10.29309/tpmj/2017.24.02.508.

Повний текст джерела

Анотація:

Objectives: To determine the frequency of hepatitis b & c viral infection insurgical patients. Study Design: Descriptive case series. Place and Duration of Study: Thisstudy was conducted at surgical department of multiple hospitals and compares the results,JPMC Karachi, Civil Hospital Naushahro Feroze and Jamshoro, Pakistan from August 2014 toDecember 2015. Methodology: All 2645 patients were admitted for emergency and electivesurgery. All patients taken detail history regarding demographic parameter and risk factorslike previous surgery, blood transfusion, barbar, Road Traffic accident, h

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Dar, Ghayas Ud Din, Muhammad Imran Qader, Shafique Ahmed Chudhary, Dania Aijaz, Shahid Imtiaz, and Tahir Naveed. "Frequency of HBsAg and Anti-HCV among Hemodialysis Patients in Three General Hospitals of Azad Kashmir." International Journal of Frontier Sciences 4, no. 1 (2020): 52–54. https://doi.org/10.5281/zenodo.3613537.

Повний текст джерела

Анотація:

<strong>ABSTRACT</strong> <strong>Background</strong>: The impact of dialysis modality on the rates and types of infectious complications has not been well studied. The aim of the present investigation was to evaluate the rates of hepatitis C virus and hepatitis B virus infections in hemodialysis patients in three general hospitals of Azad Kashmir. In dialysis patient, if left unaddressed these may lead to very fatal consequences at the individual and national level. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections represent significant public health issues globally. These infect

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Billah, Mustansar, Syed Muhammad Raza Shah, and Muhammad Mujtaba Hashir. "HEPATITIS B AND HEPATITIS C;." Professional Medical Journal 25, no. 08 (2018): 1245–51. http://dx.doi.org/10.29309/tpmj/2018.25.08.88.

Повний текст джерела

Анотація:

Objectives: To determine the frequency of HBV and HCV among blood donorscoming voluntarily at the blood bank of Ibne- Siena hospital and research centre, Multan,Pakistan, to ascertain the disease burden in the community for their future prevention andcontrol. Study Design: It was a descriptive, cross- sectional study on blood units donated byhealthy individuals coming voluntarily for blood donation, and willing to get their blood testedfor HBV, HCV. Setting: Community medicine department of Multan medical and dental collegeMultan, and blood bank of affiliated tertiary hospital, Ibn-e- Siena ho

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Geller, Stephen A. "Hepatitis B and hepatitis C." Clinics in Liver Disease 6, no. 2 (2002): 317–34. http://dx.doi.org/10.1016/s1089-3261(02)00008-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Jackson, Stephen H., and Eddie C. Cheung. "Hepatitis B and hepatitis C:." Anesthesiology Clinics of North America 22, no. 3 (2004): 357–77. http://dx.doi.org/10.1016/j.atc.2004.04.001.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Anjum, Muhammad Usman, Muhammad Safdar Khan, Nazar Muhamamd Afridi, and Syed Humayun Shah. "HEPATITIS B AND C VIRUS INFECTIONS." Professional Medical Journal 22, no. 10 (2015): 1284–88. http://dx.doi.org/10.29309/tpmj/2015.22.10.981.

Повний текст джерела

Анотація:

Patients with end stage renal disease require haemodialysis as a part of theirtreatment. The incidence of hepatitis B and C virus infection is quite high in patients undergoingmaintenance haemodialysis than in general population. This risk is specifically associatedwith use of blood and its products as well as repeated intravascular access in these patients.Objectives: To determine the seropositivity of hepatitis B and C virus infection in patientsreceiving haemodialysis. Design: Descriptive cross sectional study. Setting: NephrologyDepartment, Ayub Teaching Hospital, Abbottabad, Pakistan. Per

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Pradip, Bhaumik, and Dutta Kumar Pranab. "COMMUNITY BASED MODEL OF HEPATITIS B ELIMINATION IN TRIPURA, NORTH EAST INDIA." International Journal of Advanced Research 12, no. 01 (2024): 1268–71. http://dx.doi.org/10.21474/ijar01/18245.

Повний текст джерела

Анотація:

Liver can be affected by various virus like Hepatitis A, B, C, D, E. Hepatitiss B and C are blood borne and can cause chronic complications leading to chronic liver disease, cirrhosis and hepatocellular carcinoma. In 1984 Taiwan launched first universal vaccination against Hepatitis B with plasma derived vaccine and they could reduce the burden significantly with in a short period. In 1987 recombinant DNA vaccine become available and hepatitis B vaccination became a target area but the the program did not received proper momentum. A science based social orbanisation, Hepatitis Foundation of Tr

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Nouman, Muhammad Khuram, Bushra Zaidi, Ghulam Mohiuddin, Faryal Asif, and Muhammad Khan Malik. "HEPATITIS C." Professional Medical Journal 25, no. 03 (2018): 387–91. http://dx.doi.org/10.29309/tpmj/2018.25.03.381.

Повний текст джерела

Анотація:

Background: Hepatitis C virus (HCV) is the most communal source of non-A,non-B viral hepatitis in the world. The disease is illusory, and the majority of patients do notacquire jaundice at its onset. Treatment of hepatitis C with interferon attained a sustainedvirological response (SVR) in almost 50% of the patients with HCV infection. Viral genotype isimportant to determine the response. The present study aims to provide the incidence of relapseof HCV in patients taking interferon therapy and to identify the predictors for relapse. StudyDesign: Retrospective observational study. Setting: Depa

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Vijendra, Singh Rawat, Ranjan Neelima, Jain Isha, and Bharat Jain Savita. "Hepatitis B and Hepatitis C - Seroprevalence and Correlation with C-Reactive Protein." International Journal of Pharmaceutical and Clinical Research 15, no. 6 (2023): 2003–8. https://doi.org/10.5281/zenodo.12529982.

Повний текст джерела

Анотація:

<strong>Background: </strong>Viral hepatitis caused by Hepatitis B(HBV) and Hepatitis C virus (HCV) is a major public health problem specially in developing countries like India. <strong>Materials and Methods: </strong>Three hundred blood samples were collected from patients having clinical sign and symptoms of hepatitis and apparently healthy pregnant females. Detection of hepatitis B surface antigen, antibodies against hepatitis C virus and C reactive protein (CRP) was done in these samples. <strong>Results:</strong> The seroprevalence of HBV and HCV in our study sam

Стилі APA, Harvard, Vancouver, ISO та ін.

16

TASEER, IJAZ-UL-HAQUE, Ahsanullah M. Mirbahar, Ahsanullah M. Mirbahar, LAIQ HUSSAIN, Muhammad Aftab Akbar, and SOHAIL SAFDAR. "HEPATITIS B, HEPATITIS C a HIV." Professional Medical Journal 16, no. 03 (2009): 370–76. http://dx.doi.org/10.29309/tpmj/2009.16.03.2794.

Повний текст джерела

Анотація:

Objective: To assess the level of knowledge regarding hepatitis B, hepatitis C and HIV among general public of peripheralareas of Multan. Study design: Cross-sectional study. Setting: Peripheral areas of Multan, village Budhla Sunnat, kusba Ayazabad Marrhaland PMRC Research Centre Nishtar Medical College Multan. Duration of study: From 01.05.2007 to 30.04.2008. Subjects and methods:Medical camps were established in peripheral areas of Multan, village Budhla Sunnat and kusba Ayazabad Marrhal. It was a cross-sectionalstudy which was carried out using non-probability convenient sampling technique

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Enaleeva, D. Sh, and V. Kh Fazylov. "The role of primary care physicians in diagnosis and follow-up of patients with chronic viral hepatites B, C and D." Kazan medical journal 95, no. 3 (2014): 439–45. http://dx.doi.org/10.17816/kmj1532.

Повний текст джерела

Анотація:

By 01.01.2013 in the Republic of Tatarstan there were 23 970 Hepatitis B Surface Antigen carriers and 4546 patients with active Hepatitis B out of 28 516 registered patients who were infected with Hepatitis B. Our experience shows that not only inactive chronic Hepatitis B Surface Antigen carriers, but also patients with different clinical forms of Hepatitis B might be estimated as Hepatitis B Surface Antigen carriers. The feature of chronic viral hepatitides is a discrepancy between the scarce clinical picture and presence (in 15-30% of cases) of active inflammation in liver tissue. Since 200

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Tobokalova, S. T., D. S. Bekenova, G. M. Zairova, Z. Sh Nurmatov, Zh N. Nazarbaeva, and Zh T. Aytieva. "Epidemiological features of acute and chronic hepatitis B in the Kyrgyz Republic over the 20-year period (1997-2017)." Kazan medical journal 99, no. 6 (2018): 986–93. http://dx.doi.org/10.17816/kmj2018-986.

Повний текст джерела

Анотація:

Aim. To determine epidemiological features of acute and chronic viral hepatitis B in the Kyrgyz Republic over the period 1997-2017. Меthоds. Analysis was performed on data bases of the National accounting forms on treated cases of acute and chronic hepatitis B cumulated by the Medical Information Centre of the Ministry of Health of Kyrgyz Republic for the period of 1997 to 2017 as well as 384 medical records of patients with chronic hepatitis B treated in the Hepatologic Centre “Tsadmir”. Results. In the Kyrgyz Republic among all acute cases of acute viral hepatitides, hepatitis A comprises 60

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Kosagovskaya, I. I., and E. V. Volchkova. "THE MEDICO-SOCIAL ASPECTS OF VIRAL HEPATITIDES WITH THE PARENTERAL WAY OF TRANSMISSION." Epidemiology and Infectious Diseases 18, no. 1 (2013): 28–39. http://dx.doi.org/10.17816/eid40715.

Повний текст джерела

Анотація:

The article is devoted to current epidemiological, social and economic aspects of parenteral viral hepatitis B and C. Statistical data on the incidence, prevalence, outcomes for viral hepatitides are provided. Prior medical and social factors influencing the formation of the epidemiological situation and the activity of infection with viral hepatitis B and C, including gaining the importance of the prevalence of parenterally transmitted viral hepatitis among drinkers, drug users, and HIV infected cases have been analyzed. The issues of economic losses and economic costs required to treat patie

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Dr., Tariq Zaffar Shaikh* Dr. Muhammad Adnan Bawany Dr. Mona Humaira Dr. Mashal Dad Dr. Najeeb Ullah Ansari Dr. Ayesha Jamil Dr. Zulfiqar Ali Qutrio Baloch and Dr. Muhammad Ayyaz. "FREQUENCY, ETIOLOGY AND CLINICAL PROFILE OF PATIENT WITH ACUTE VIRAL HEPATITIS AT TERTIARY CARE HOSPITAL." Indo American Journal of Pharmaceutical Sciences 04, no. 09 (2017): 3000–3003. https://doi.org/10.5281/zenodo.893306.

Повний текст джерела

Анотація:

Objective: To determine the frequency, etiology and clinical profile of patient with acute viral hepatitis at tertiary care hospital. Patients and Methods: This study of cross sectional type was conducted at tertiary care hospital and included patients of ≥11 years of age, either gender with clinical and biochemical profile suggestive of acute hepatitis, at least one positive serological viral marker and ultrasound abdomen shown no evidence of intra as well as extra hepatic biliary obstruction. The following serological tests were also advised for correct etiological diagnosis anti-HAV (IgM) b

Стилі APA, Harvard, Vancouver, ISO та ін.

21

IQBAL, MUHAMMAD ZAFAR, MUHAMMAD AZEEM, and MUHAMMAD RAZZAQ MALIK. "HEPATITIS 'B' AND 'C'." Professional Medical Journal 18, no. 01 (2011): 69–74. http://dx.doi.org/10.29309/tpmj/2011.18.01.1861.

Повний текст джерела

Анотація:

Background: Hepatitis B and C is a global problem. The prevalence of hepatitis B and C in orthopedic patients is quite high with the common risk factors: previous history of surgery or blood transfusion. Objectives: The objectives of this study were to, "Find out the prevalence of Hepatitis B and C and their risk factors in patients admitted in Orthopedic Unit of Sheikh Zayed Medical College Hospital Rahim Yar Khan.”. Design & Duration: This was a prospective cohort study. The duration was from July 2009 to December 2009. Patients and Methods: This study was conducted in Orthopedic Departm

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Munawar, Ali Khan, Faisal Khilji Muhammad, Rauf Janjua Abdul, Imran Muhammad, and Hakan Altintas Kerim. "Hepatitis B and C related knowledge, attitudes and practices of health care workers in Azad Kashmir, Pakistan –A potentially disastrous area." International Journal of Endorsing Health Science Research 7, no. 1 (2019): 39–46. https://doi.org/10.29052/IJEHSR.v7.i1.2019.39-46.

Повний текст джерела

Анотація:

Abstract <strong>Background:</strong> Azad Kashmir, Pakistan is potentially dangerous area for earthquake disasters. Knowledge, attitude and practices (KAP) of health care workers (HCW’s) in this region is essential to prevent spread of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) in case of disaster. <strong>Methodology: </strong>This descriptive observational prospective study was carried out to assess the HCW’s KAP regarding HBV and HCV in major hospitals of Muzaffarabad, Azad Kashmir, Pakistan. A validated study questionnaire was distributed among 320 HCW&rsquo

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Mohammad, Mohammad O. "Prevalence of Hepatitis-B and Hepatitis-C among Blood Donors in Sulaimani City." Journal of Zankoy Sulaimani - Part A 9, no. 1 (2005): 115–24. http://dx.doi.org/10.17656/jzs.10155.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Midhin, Adel, and Narmeen Tawfeeq. "Health- related quality of life for adult patient with chronic viral hepatitis B and C." Iraqi National Journal of Nursing Specialties 25, no. 3 (2018): 71–78. http://dx.doi.org/10.58897/injns.v25i3.145.

Повний текст джерела

Анотація:

Objective(s): This study aims to assess health related quality of life among Iraqi patients with chronic viral hepatitisB and C also to find out the relationship between health related quality of life and patients demographiccharacteristic and to design a new measurement scale for assessing QoL among viral hepatitis B and C patientswhich can be suitable to be adopted for Iraqi patientsMethodology: A descriptive quantitative study is carried out at Gastroenterology and Hepatology TeachingHospital from February, 1st, 2011 to August 30th 2011, Anon probability (purposive sample) of (100) chronic

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Dr., Iqra Butt Dr. Danyal Ashraf Dr. Hamza Tanvir Alam. "STUDY TO KNOW THE HEPATITIS B AND C VIRUS PREVALENCE IN HEALTHY BLOOD DONORS." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 05, no. 11 (2018): 12810–13. https://doi.org/10.5281/zenodo.1493039.

Повний текст джерела

Анотація:

<strong><em>Objective:</em></strong><em> To determine seropositivity of viral hepatitis B and C in healthy blood donors attended the Blood Transfusion department of Holy Family and Benazir Bhutto Hospital.</em> <strong><em>Study Design: </em></strong><em>A Retrospective Study.</em> <strong><em>Place and Duration:</em></strong><em> In the Blood Transfusion department of Holy Family and Benazir Bhutto Hospital, Rawalpindi for Six month duration from January 2018 to June 2018.</em> <strong><em>Methods:</em></strong><em> Blood donors who were admitted to the Blood Transfusion department of Holy Fa

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Marcellin, Patrick. "Hepatitis B and hepatitis C in 2009." Liver International 29 (January 2009): 1–8. http://dx.doi.org/10.1111/j.1478-3231.2008.01947.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Itelima, Janet. "P-E6 Hepatitis B and Hepatitis C." JAIDS Journal of Acquired Immune Deficiency Syndromes 77 (April 2018): 62. http://dx.doi.org/10.1097/01.qai.0000532499.01912.09.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Calmet Schwartzmann, Fernando H., and Fernando H. Calmet Bruhn. "Hepatitis C." Diagnóstico 56, no. 1 (2018): 24–30. http://dx.doi.org/10.33734/diagnostico.v56i1.119.

Повний текст джерела

Анотація:

El virus de la hepatitis C (VHC) es un virus monocatenario ARN perteneciente al género Hepacivirus de la familia Flaviviridae. En la década de 1970, tras el descubrimiento de hepatitis Ay B, se hizo claro que había casos de hepatitis post-transfusión que no podían ser explicados por estos virus, llevando a la descripción de hepatitis "no A, no B". No fue hasta 1989 que se aisló el VHC por primera vez y entre 1990 y 1992 se desarrolló y refinó una prueba de anticuerpos anti-VHC que fue implementado en los bancos de sangre, llevando a una gran reducción de la transmisión de este virus a nivel mu

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Calmet Schwartzmamn, Fernando H., and Fernando H. Calmet Bruhn. "Hepatitis C." Diagnóstico 56, no. 1 (2020): 24–30. http://dx.doi.org/10.33734/diagnostico.v56i1.166.

Повний текст джерела

Анотація:

El virus de hepatitis C (VHC) es un virus monocatenario ARN perteneciente al género Hepacivirus de la familia Flaviviridae. En la década de 1970, tras el descubrimiento de hepatitis A y B, se hizo claro que había casos de hepatitis post-transfusión que no podían ser explicados por estos virus, llevando a la descripción de hepatitis ''no A, no B''. No fue hasta 1989 que se aisló el VHC por primera vez y emtre 1990 y 1992 se desarrolló y refinó una prueba de anticuerpos anti-VHC que fue implementado en los bancos de sangre, llevando a una gran reducción de la transmisión de este virus a nivel mu

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Shaheen, Shugufta, Anila Mahmood, and Salma Khushk. "HEPATITIS B & C." Professional Medical Journal 22, no. 05 (2015): 554–58. http://dx.doi.org/10.29309/tpmj/2015.22.05.1266.

Повний текст джерела

Анотація:

Hepatitis B and C are serious global public health problems. Objectives:The objective of this study is to assess the knowledge regarding HBV and HCV transmission,risk factors and prevention among women attending the OBS/GYN clinic. Study Design:Descriptive observational study. Period: 1st January 2012 up to 31st of December 2013.Setting: Gynae Department Lady Dufferin Hospital Karachi and Al Tibiri Medical College IsraUniversity Karachi campus. Methods: Total 123 patients were included in study. All the patientswho were admitted during the study period from gynecological surgery were included

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Moradpour and Blum. "Diagnostik der Hepatitis B und C." Praxis 94, no. 3 (2005): 66–72. http://dx.doi.org/10.1024/0369-8394.94.3.66.

Повний текст джерела

Анотація:

Die Diagnose der Hepatitis B und C kann heute mit hoher Sensitivität und Spezifität durch einfache und kostengünstige serologische Tests gesichert werden. Als Suchtests werden HBsAg bzw. anti-HBc für die Hepatitis B und anti-HCV für die Hepatitis C eingesetzt. Im Hinblick auf eine antivirale Therapie und für das Monitoring unter Therapie sind der Nachweis von HBeAg bzw. HBV DNA bei der Hepatitis B und die Bestimmung des Genotyps sowie der qualitative bzw. quantitative Nachweis der HCV RNA bei der Hepatitis C heute Standard. Eine Leberbiopsie zur Objektivierung des Entzündungsgrades und des Fib

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Marinelli, RMA, M. Delle Monache, R. Gerardi, et al. "Liver Pathology in Cytomegalovirus Infection Associated with Hepatitis B Virus." Journal of International Medical Research 21, no. 3 (1993): 154–57. http://dx.doi.org/10.1177/030006059302100306.

Повний текст джерела

Анотація:

A retrospective study was carried out in 56 patients to establish the association of cytomegalovirus (CMV) with active or inactive hepatitis B virus (HBV) infection as a possible risk factor in the development of severe liver disease. Patients with positive CMV serology and active or inactive HBV infection had elevated alanine aminotransferase activity and had a relatively high incidence of more severe lesions (chronic hepatitis and active cirrhosis), In the absence of CMV, only one case of cirrhosis was identified compared with seven cases of hepatic fibrosis. By analogy with hepatitis C viru

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Asratyan, A. A., D. V. Solovyov, and E. V. Rusakova. "Present Epidemical Situation of Viral Hepatitides and Tuberculosis Morbidity Rates in Moscow." Epidemiology and Vaccine Prevention 14, no. 3 (2015): 42–48. http://dx.doi.org/10.31631/2073-3046-2015-14-3-42-48.

Повний текст джерела

Анотація:

Analysis of dynamics and trends in parenteral viral hepatitides and tuberculosis morbidity rates in Moscow for 1999 - 2013. Analysis of dynamics and trends in parenteral viral hepatitides and tuberculosis morbidity rates in Moscow in 1999 - 2013 based on the statistical data of Moscow regional information collection of federal state-financed healthcare institution Moscow city centre of hygiene and epidemiology. In aggregate, 1389 cards and the data of 24 forms were processed. The tuberculosis morbidity rate of the population of the city of Moscow in 1999 - 2009 exhibited tendency towards incre

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Aisyi, Mururul, and Alan R. Tumbelaka. "Pola Penyakit Infeksi pada Thalassemia." Sari Pediatri 5, no. 1 (2016): 27. http://dx.doi.org/10.14238/sp5.1.2003.27-33.

Повний текст джерела

Анотація:

Pasien thalassemia rentan terhadap infeksi akibat faktor penyakitnya maupun akibatpengobatan. Kelebihan besi yang terjadi akibat transfusi berulang mempengaruhi sistimimun, menekan aksi kemotaksis fagositosis, mikrobiosidal leukosit mononuklear danpolimorfonuklear. Penularan infeksi melalui transfusi seperti virus hepatitis, HIV danCMV merupakan komplikasi transfusi yang ditakuti. Infeksi virus hepatitis yangditularkan melalui transfusi antara lain hepatitis A, Hepatitis B, hepatitis C dan hepatitisD. hepatitis C mungkin merupakan penyebab utama sirosis hepatitis pada pasienthalassemia yang me

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Shamsa, Arshad Butt, Akram Ammara, Firdous Maryam, and Hussain Shafaat. "Analysis of Risk Factors of Hepatitis B and Hepatitis C in Pakistan." systematic reviews in pharmacy 12, no. 4 (2021): 224–26. https://doi.org/10.5281/zenodo.4876028.

Повний текст джерела

Анотація:

ABSTRACT Introduction: Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) are among the principal causes of severe liver disease, including hepatocellular carcinoma and cirrhosis-related end-stage liver disease. The World Health Organization (WHO) estimates that there are 350 million people with chronic HBV infection and 170 million people with chronic HCV infection worldwide. Aims and objectives: The basic aim of the study is to find the risk factors of hepatitis B and C among local population of Pakistan. Methodology of the study: This descriptive study was conducted at Holy Family Hospital

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Al-Khazraji, Khalid A. "Comparison study between the treatment of Hepatitis C virus with (peg-interferon, ribavirin, silymarin) and (peg-interferon, ribavirin) in Baghdad teaching hospital." Journal of the Faculty of Medicine Baghdad 59, no. 1 (2017): 14–18. http://dx.doi.org/10.32007/jfacmedbagdad.591150.

Повний текст джерела

Анотація:

Background: Infection with Hepatitis C virus (HCV) is a major cause of chronic liver disease, WHO estimated that about 170 million people are infected with Hepatitic C virus, Silymarin (Legalon) have been recently shown to be effective in treatment of Hepatitic C virus infection.Objectives: The effectiveness of Legalon (Silymarin) on viral load in patients with Hepatitic C virus infection.Patients and methods: A prospective case – control study included 400 patients with Hepatitis C virus infection. 200 patients (group A) were treated with (peg-interferon, ribavirin, silymarin) the other 200 p

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Cramp, M. E., H. C. Grundy, R. M. Perinpanayagam, and D. E. Barnado. "Seroprevalence of Hepatitis B and C Virus in Two Institutions Caring for Mentally Handicapped Adults." Journal of the Royal Society of Medicine 89, no. 7 (1996): 401–2. http://dx.doi.org/10.1177/014107689608900712.

Повний текст джерела

Анотація:

Hepatitis B virus infection is common in institutions caring for the mentally handicapped. Hepatitis B virus and hepatitis C virus share routes of transmission but the prevalence of hepatitis C virus infection in this population is unknown. We have tested 101 patients from two institutions in South-East England caring for adults with mental handicap for the presence of hepatitis C antibody, hepatitis B core antibody, and if necessary hepatitis B surface antigen. None tested positive for hepatitis C antibody, but 43 had hepatitis B core antibody of whom 14 were chronic carriers positive for hep

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Moore, Kevin J., Erin Dunn, Stacey L. Tannenbaum, and Tulay Koru-Sengul. "Racial/ethnic disparities in liver cancer-attributable hepatitis infections in the U.S. population." Journal of Clinical Oncology 33, no. 3_suppl (2015): 259. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.259.

Повний текст джерела

Анотація:

259 Background: According to the American Cancer Association, hepatitisB and Cinfections may raise liver cancer risk. We identify population-specific cancer-attributable hepatitis prevalence to discern disparities across race/ethnicity for liver cancer risk. Methods: Data from 1999-2012 National Health and Nutrition Examination Survey (NHANES) were used to determine prevalence, unadjusted odds ratios (OR) with 95% confidence intervals (95%CI) for non-Hispanic-Whites (NHW), non-Hispanic-Blacks (NHB), Mexican-Americans, other Hispanics, and other race of hepatitis, taking complex sampling design

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Namıduru, Emine Siber, and Mustafa Namıduru. "Oxidative stress in viral HEPATITIS B and C." Asian Pacific Journal of Health Sciences 6, no. 4 (2019): 47–48. http://dx.doi.org/10.21276/apjhs.2019.6.4.10.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Riaz, Haroon, Muhammad Zahid Latif, Syed Waseem Ahmad Mujtaba, Rahila Nizami, and Muhammad Atif Qureshi. "HEPATITIS B AND C;." Professional Medical Journal 24, no. 02 (2017): 244–48. http://dx.doi.org/10.29309/tpmj/2017.24.02.516.

Повний текст джерела

Анотація:

Objectives: This study was conducted to find out the prevalence of HepatitisB and C in two different areas of southern Punjab. Settings: Layyah and Rajan pur region ofsouthern Punjab Pakistan. Study Design: Descriptive, cross sectional study. Study Period:This study was conducted during the period of August to November 2014. Methods: 1824subjects were selected from both male and female population visiting the free eye camps atLayyah and Rajanpur region. All the selected subjects were tested for HBsAg and for anti-HCVantibodies with Immuno-chromatographic test kit. Results: The cumulative preva

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Aslam, Muhammad Naveed, Muhammad Nadeem, and Umar Farooq Qureshi. "HEPATITIS B AND C." Professional Medical Journal 23, no. 01 (2016): 025–28. http://dx.doi.org/10.29309/tpmj/2016.23.01.782.

Повний текст джерела

Анотація:

Background: Pakistan is a developing country of 180 million people with lowhealth and educational standards. According to the Human Development Index of the UnitedNations, it is ranked 146th out of 187 countries. Objective: To know the actual disease burdenof Chronic Hepatitis Viruses B and C in Southern Punjab. Study Design: Cross-sectional,Observational study. Setting: Ibn-e-Sina Hospital and Research Centre. Period: March 2010 toFebruary 2014. Methodology: A total of 26800 people from general population were includedin the present study. Free vaccination camps were established in rural and

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Mohan, Neelam, Wikrom Kamsakul, Stefen Wirth, Tomoo Fujisawa, and Danial D’agostino. "Hepatitis B and C." Journal of Pediatric Gastroenterology and Nutrition 55, no. 5 (2012): 631–35. http://dx.doi.org/10.1097/mpg.0b013e318272b61e.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Dhillon, Raje, and Maria Paraskevopoulou. "Hepatitis B and C." Journal of the Intensive Care Society 15, no. 2 (2014): 135–41. http://dx.doi.org/10.1177/175114371401500211.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Karnsakul, Wikrom, and Kathleen B. Schwarz. "Hepatitis B and C." Pediatric Clinics of North America 64, no. 3 (2017): 641–58. http://dx.doi.org/10.1016/j.pcl.2017.01.007.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Mysore, Krupa R., and Daniel H. Leung. "Hepatitis B and C." Clinics in Liver Disease 22, no. 4 (2018): 703–22. http://dx.doi.org/10.1016/j.cld.2018.06.002.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Gerlich, W. H. "Hepatitis B und C." Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 47, no. 4 (2004): 369–78. http://dx.doi.org/10.1007/s00103-004-0811-x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Duddempudi, Anupama T., and David E. Bernstein. "Hepatitis B and C." Clinics in Geriatric Medicine 30, no. 1 (2014): 149–67. http://dx.doi.org/10.1016/j.cger.2013.10.012.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Prokopovych, M. V., I. H. Hryzhak, M. M. Bahrii, and V. M. Kostyuk. "PATHOMORPHOLOGICAL CHANGES IN THE LIVER CAUSED BY HEPATITIS B, C, B+C VIRUSES IN THE DECEASED HIV-INFECTED PERSONS." Інфекційні хвороби, no. 4 (November 24, 2023): 18–28. http://dx.doi.org/10.11603/1681-2727.2023.4.14243.

Повний текст джерела

Анотація:

Pathohistological peculiarities of liver histological preparations of 75 HIV-infected deceased people with chronic viral hepatitis which diagnosed during their life: hepatitis B was in 8, C – in 24, B+C – in 43 patients. It was determined that in all patients (100.0 %), with any type of chronic hepatitis (B, C or B+C) there was a lymphocyte-macrophage infiltration of portal tracts and stroma. In persons with hepatitis B there were a focal and periportal necrosis of hepatocytes in 100.0 % of patients, hydropic dystrophy of hepatocytes - in 87.5 % and liver cirrhosis – in 25.0 %. In patients wit

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Austin, Publishing Group. "Tackling the Burden of Viral Hepatitis in India: A Call for Collaborative Efforts." Journal of Hepatitis Research 8, no. 1 (2023): 1049. https://doi.org/10.26420/jhepatres.2023.1049.

Повний текст джерела

Анотація:

Viral hepatitis is defined as a widespread infectious disease involving the inflammation of liver caused by hepatitis virus A, B, C, D and E. The majority of deaths linked to viral hepatitis are caused by HBV, HCV, and HDV, which are transmitted parenterally and induce chronic hepatitis with distant sequelae like liver cirrhosis and hepatocellular cancer [1]. According to WHO latest estimates, viral hepatitis is now acknowledged as a serious public health problem in India with over 40 million people chronically infected with HBV and six to twelve million people with HCV. In a study dated in 20

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Icole, F., J. P. Bronowicki, C. Jeannoel, P. Besancon, and F. Boulanger. "Screening for hepatitis C in psychiatric population." European Psychiatry 64, S1 (2021): S90—S91. http://dx.doi.org/10.1192/j.eurpsy.2021.267.

Повний текст джерела

Анотація:

IntroductionA meta-analysis from 2016 estimates prevalence of hepatitis C to be superior in people with severe mental illness than general population. In France, positivity for hepatitis C is estimated at 0,75% of general population and 0.3% with a detectable viral load. No recent study was conducted to determine seroprevalence of hepatitis C in population admitted in psychiatric institution.ObjectivesThe aims of this study are to determine seroprevalence of hepatitis C in population admitted in psychiatric institution and describe the profile of infected patients.MethodsFrom january 2020 to o

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!